Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Deepak L Bhatt

Showing results (561-570 of 1,708) with videos related to

Pageof 171
Sort By:
Medrxiv : the Preprint Server for Health Sciences|July 1, 2024
Effects of catheter-based renal denervation in hypertension: a systematic review and meta-analysisDavor Vukadinović, Lucas Lauder, David E Kandzari, et al.
European Heart Journal Open|January 4, 2024
Ticagrelor or prasugrel vs. clopidogrel in patients with atrial fibrillation undergoing percutaneous coronary intervention for myocardial infarctionSissel J Godtfredsen, Kristian H Kragholm, Anna Meta Dyrvig Kristensen, et al.
Clinical Cardiology|July 20, 2010
Assessment of atherothrombosis and its treatment in Mexico: first-year data of the REACH RegistryEfraín Gaxiola, Luis Eng-Ceceña, Fernando Ortiz-Galván, et al.
European Journal of Preventive Cardiology|April 1, 2011
Relation between body mass index, waist circumference, and cardiovascular outcomes in 19,579 diabetic patients with established vascular disease: the REACH RegistryJean Dallongeville, Deepak L Bhatt, P H Gabriel Steg, et al.
BMJ (Clinical Research Ed.)|July 16, 2015
Real world effectiveness of primary implantable cardioverter defibrillators implanted during hospital admissions for exacerbation of heart failure or other acute co-morbidities: cohort study of older patients with heart failureChih-Ying Chen, Lynne Warner Stevenson, Garrick C Stewart, et al.
The American Journal of Cardiology|September 26, 2006
Use of platelet glycoprotein IIb/IIIa inhibitors in saphenous vein graft percutaneous coronary intervention and clinical outcomesJuhana Karha, Hitinder S Gurm, Vivek Rajagopal, et al.
The American Journal of Cardiology|July 28, 2004
Effect of clopidogrel pretreatment on periprocedural rise in C-reactive protein after percutaneous coronary interventionDeepak P Vivekananthan, Deepak L Bhatt, Derek P Chew, et al.
NPJ Digital Medicine|October 24, 2022
Predicting radiocephalic arteriovenous fistula success with machine learningPatrick Heindel, Tanujit Dey, Jessica D Feliz, et al.
Stroke|October 27, 2021
Antithrombotic Therapy for Stroke Prevention in Patients With Ischemic Stroke With Aspirin Treatment FailureJay B Lusk, Haolin Xu, Eric D Peterson, et al.
JACC. Cardiovascular Interventions|July 8, 2017
Temporal Trends, Complications, and Predictors of Outcomes Among Nonagenarians Undergoing Percutaneous Coronary Intervention: Insights From the Veterans Affairs Clinical Assessment, Reporting, and Tracking ProgramAbhishek C Sawant, Kevin Josey, Mary E Plomondon, et al.
Pageof 171

Showing results (561-570 of 1,708) with videos related to

Sort By:
Pageof 171
Medrxiv : the Preprint Server for Health Sciences|July 1, 2024
Effects of catheter-based renal denervation in hypertension: a systematic review and meta-analysisDavor Vukadinović, Lucas Lauder, David E Kandzari, et al.
European Heart Journal Open|January 4, 2024
Ticagrelor or prasugrel vs. clopidogrel in patients with atrial fibrillation undergoing percutaneous coronary intervention for myocardial infarctionSissel J Godtfredsen, Kristian H Kragholm, Anna Meta Dyrvig Kristensen, et al.
Clinical Cardiology|July 20, 2010
Assessment of atherothrombosis and its treatment in Mexico: first-year data of the REACH RegistryEfraín Gaxiola, Luis Eng-Ceceña, Fernando Ortiz-Galván, et al.
European Journal of Preventive Cardiology|April 1, 2011
Relation between body mass index, waist circumference, and cardiovascular outcomes in 19,579 diabetic patients with established vascular disease: the REACH RegistryJean Dallongeville, Deepak L Bhatt, P H Gabriel Steg, et al.
BMJ (Clinical Research Ed.)|July 16, 2015
Real world effectiveness of primary implantable cardioverter defibrillators implanted during hospital admissions for exacerbation of heart failure or other acute co-morbidities: cohort study of older patients with heart failureChih-Ying Chen, Lynne Warner Stevenson, Garrick C Stewart, et al.
The American Journal of Cardiology|September 26, 2006
Use of platelet glycoprotein IIb/IIIa inhibitors in saphenous vein graft percutaneous coronary intervention and clinical outcomesJuhana Karha, Hitinder S Gurm, Vivek Rajagopal, et al.
The American Journal of Cardiology|July 28, 2004
Effect of clopidogrel pretreatment on periprocedural rise in C-reactive protein after percutaneous coronary interventionDeepak P Vivekananthan, Deepak L Bhatt, Derek P Chew, et al.
NPJ Digital Medicine|October 24, 2022
Predicting radiocephalic arteriovenous fistula success with machine learningPatrick Heindel, Tanujit Dey, Jessica D Feliz, et al.
Stroke|October 27, 2021
Antithrombotic Therapy for Stroke Prevention in Patients With Ischemic Stroke With Aspirin Treatment FailureJay B Lusk, Haolin Xu, Eric D Peterson, et al.
JACC. Cardiovascular Interventions|July 8, 2017
Temporal Trends, Complications, and Predictors of Outcomes Among Nonagenarians Undergoing Percutaneous Coronary Intervention: Insights From the Veterans Affairs Clinical Assessment, Reporting, and Tracking ProgramAbhishek C Sawant, Kevin Josey, Mary E Plomondon, et al.
Pageof 171